跳至主要内容
临床试验/NCT02814487
NCT02814487已完成不适用

A Pilot Validation Study Comparing "DAM" a Smartphone Application With the Composite MSFC Score Intra-individually Among Multiple Sclerosis Patients

Ad scientiam0 个研究点目标入组 30 人开始时间: 2015年12月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Ad scientiam
入组人数
30
主要终点
correlation between the MSFC score and the DAM score

研究概览

简要总结

Multiple Sclerosis Functional Composite score (MSFC) is one of the gold standard for multiple sclerosis (MS) patient clinical evaluation. However, its practical implementation is not always optimal as it can prove to be very time consuming. Moreover, it often constrains the range of tests used and is not a particularly good marker for patient real life disability status.

A mobile application called Digital Self-Assessment for Multiple Sclerosis (DAM) was developed in order to replicate each of MSFC tests available in order to assess MS progression in the patient environment.

详细描述

Patients are selected during a consultation at the Neurology department of the Pitié-Salpêtrière Hospital (France). Each patient is given access to DAM on their own or a provided iPhone. During the enrolment visit, patients have to complete a MSFC and DAM evaluation (V0). Through a push-notification on their phone, patients are reminded to perform two DAM evaluations at home at days 30 (V1) and 60 (V2). At day 90 (V3), they have to come back to hospital for a second MSFC and DAM evaluation

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with an established diagnosis of Multiple sclerosis according to the MacDonald criterias whatever the progression stage, that are monitored by Dr. Maillart as part of her consultation at the Neurology department of the Pitié-Salpêtrière Hospital.
  • Patients with an iPhone (at iOS 8 or higher).
  • Patients age ≥18 years.
  • Patients with an initial score of EDSS between 0 to 6.5
  • No attack since at least 1 month
  • Last Solumedrol injection at least 1 month ago

排除标准

  • Patients who are not capable of using a smartphone application.
  • Patients who do not have the capacity to give their consent.
  • Patients who do not speak French
  • Patients who are bedridden or with a daily activity of less than 2 hours per day
  • Patients with acute asthenia
  • Patients experiencing an attack once enrolled in the study (will be considered as dropouts)

结局指标

主要结局

correlation between the MSFC score and the DAM score

时间窗: At Day 0

次要结局

  • correlation between the the MSFC and the DAM score(At Day 90)
  • correlation between the DAM score(At Day 60 and Day 90)

研究者

发起方
Ad scientiam
申办方类型
Other
责任方
Sponsor

相似试验